RadComp

Mark Bolton: RadComp Trial Compares Proton and Photon Therapy in Breast Cancer

Mark Bolton, Radiation Oncologist, shared an article on X:

“Radcomp: Ph 3 RCT proton vs photon for breast cancer with CNI ‘No clinically meaningful differences by treatment arm in the PROMIS Fatigue total score, Satisfaction with Breast Cosmetic Outcomes score, BREAST-Q total score, and FACT-B trial outcome index score’.

Main question: What is a clinically meaningful difference? Certainly not a fixed single value – this is a distribution.”

RadComp

More from Mark Bolton on OncoDaily.